The immune system can be divided into innate and adaptive components. The more recently understood innate immune system serves to immediately recognize pathogenassociated molecular patterns (PAMPs) and control infection through elaboration of proinflammatory cytokines and chemokines that recruit inflammatory cells such as neutrophils and monocytes. It is responsible for containing an infection until the adaptive immune system can orchestrate an antigenspecific immune response with T cells and B cells. Innate immune recognition relies on germline-encoded receptors that recognize a limited number of highly conserved structures found exclusively in microbial pathogens. Among these germline-encoded pathogen-recognition receptors, Toll-like receptors (TLRs) are members of a conserved interleukin-1 (IL-1) superfamily of transmembrane receptors that recognize PAMPs. A total of 13 TLRs have been described, although some of the ligands for these TLRs have not been determined. The spectrum of pathogens recognized by TLRs includes Gram-positive and Gram-negative bacteria, yeast, and viruses. As an example, TLR4 interacts with lipopolysaccharide (LPS), resulting in the recruitment of the adapter molecule MyD88, phosphorylation of the IL-1 receptor-associated kinase (IRAK) followed by tumor necrosis factor (TNF) receptor-a associated factor 6 (TRAF6). Most TLRs use MyD88 as an adapter molecule, although other adapter molecules such as TRIF are utilized by TLR3. Recruitment of TRAF6 leads to the phosphorylation of I Bkinases and release of NFB as well as activation of the mitogen activated protein kinase (MAPK) pathway. The activation of NFB triggers a potent proinflammatory response in most cell types expressing TLRs. Given the complexity of the commensal flora, the question then becomes, how does the intestinal mucosa regulate TLR signaling? In particular, how does TLR signaling discriminate between commensal and pathogenic bacteria? The expression and function of several TLRs have been examined in the intestine. In general, TLR expression by intestinal epithelial cells is low compared with hematopoietic cells such as macrophages. Human intestinal epithelial cells normally express TLR3 and TLR5, while TLR2 and TLR4 are only barely detectable .1–4 However, TLR4 is up regulated in both Crohn’s disease (CD) and ulcerative colitis (UC), while the expression of TLR2 and TLR5 remains unchanged.5–7 Inflammatory cytokines such as IFNand TNFincrease expression of TLR4 and MD-2, resulting in increased LPS responsiveness.4,8 In addition, expression of TLR4 and TLR2 is increased in lamina propria macrophages in IBD.5 The observation that expression of certain TLRs is increased in inflammatory bowel disease (IBD) may be a secondary event because of the presence of inflammatory mediators. Nevertheless, the increased expression of TLRs may result in inadvertent hyperreactivity to the commensal flora. It is also possible that a subset of IBD patients is characterized by dysregulated, constitutively active TLR signaling. On the flip side of implicating increased TLR signaling as propagating or contributing to inflammation, decreased TLR signaling might also play a detrimental role in IBD. First, polymorphisms in TLR genes have been associated with IBD.9 Two missense mutations in the extracellular domain of TLR4 have been associated with hyporesponsiveness to inhaled LPS and protection against atherosclerosis. The association with IBD is not as straightforward, with 1 study showing a positive association with UC,10 another showing a positive association with both CD and UC,11 and another showing no association with CD.12 A large consortium of American and Canadian investigators has found a positive association of TLR4 polymorphisms with Crohn’s disease (odds ratio 1.33).13 Polymorphisms in TLR9 have also been linked with CD.14 These data could be considered along with the known association of CD with mutations in the Nod2/ CARD15 gene, namely deficient innate immune responses may play a role in IBD susceptibility. Multiple models could be drawn as to how defective TLR responsiveness could lead to IBD susceptibility. TLR5 / mice are more susceptible to spontaneous and induced colitis.15 In this regard, TLR4 has been most studied with respect to its function in animal models of inflammation. TLR4 appears to be important for healing of the injured intestinal epithelium.16 We and others have described decreased epithelial proliferation in TLR4 or MyD88-deficient mice.16–18 These data suggest a role for TLR4 in regulation of intestinal epithelial cell proliferation. MyD88-deficient mice From the Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Florida, USA. Copyright © 2008 Crohn’s & Colitis Foundation of America, Inc. DOI 10.1002/ibd.20632 Published online in Wiley InterScience (www.interscience.wiley.com).
[1]
S. Akira,et al.
Deletion of TLR5 results in spontaneous colitis in mice.
,
2007,
The Journal of clinical investigation.
[2]
R. Xu,et al.
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.
,
2007,
Gastroenterology.
[3]
A. Shelling,et al.
Has Toll-Like Receptor 4 Been Prematurely Dismissed as an Inflammatory Bowel Disease Gene? Association Study Combined With Meta-Analysis Shows Strong Evidence for Association
,
2007,
The American Journal of Gastroenterology.
[4]
R. Medzhitov,et al.
Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88
,
2007,
Science.
[5]
M. Daly,et al.
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases
,
2007,
Genes and Immunity.
[6]
C. A. de la Motte,et al.
The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.
,
2007,
Immunity.
[7]
Yu-Tseung Liu,et al.
Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells
,
2006,
Nature Cell Biology.
[8]
R. Xu,et al.
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.
,
2006,
Gastroenterology.
[9]
G. Veres,et al.
Increased expression of Toll‐like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease
,
2007,
Clinical and experimental immunology.
[10]
R. Xu,et al.
Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
,
2005,
American journal of physiology. Gastrointestinal and liver physiology.
[11]
T. Hirayama,et al.
This information is current as Signaling in Intestinal Epithelial Cells-Defensin-2 Expression Is Regulated by TLR β and
,
2004
.
[12]
Ruslan Medzhitov,et al.
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
,
2004,
Cell.
[13]
J. Glas,et al.
Crohn's disease is associated with a toll-like receptor-9 polymorphism.
,
2004,
Gastroenterology.
[14]
H. Drummond,et al.
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?
,
2004,
Genes and Immunity.
[15]
T. Mussack,et al.
Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.
,
2004,
Clinical immunology.
[16]
G. Gerken,et al.
Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.
,
2004,
Gastroenterology.
[17]
K. Van Steen,et al.
Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis
,
2004,
Gut.
[18]
D. Podolsky,et al.
Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells.
,
2004,
Gastroenterology.
[19]
S. Akira,et al.
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.
,
2004,
Gastroenterology.
[20]
D. Podolsky,et al.
Gamma Interferon Augments the Intracellular Pathway for Lipopolysaccharide (LPS) Recognition in Human Intestinal Epithelial Cells through Coordinated Up-Regulation of LPS Uptake and Expression of the Intracellular Toll-Like Receptor 4-MD-2 Complex
,
2003,
Infection and Immunity.
[21]
K. Michelsen,et al.
Human Intestinal Epithelial Cells Are Broadly Unresponsive to Toll-Like Receptor 2-Dependent Bacterial Ligands: Implications for Host-Microbial Interactions in the Gut 1
,
2003,
The Journal of Immunology.
[22]
M. Abreu,et al.
Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1
,
2001,
The Journal of Immunology.
[23]
G. Rogler,et al.
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation.
,
2001,
Gastroenterology.
[24]
D. Podolsky,et al.
Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease
,
2000,
Infection and Immunity.
[25]
T. Hirayama,et al.
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells.
,
2004,
Journal of immunology.